Pricing Log in Create free account
Friday 6 November 2026 Export ITGR’s income statement to Excel — free account

Integer Holdings Corporation

ITGR Healthcare Medical Devices

Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024.

Revenue
−3.86%
EPS
−61.0%
Free cash flow
−65.2%
Total debt
+4.06%

Quarter to September 2026, against a year earlier

126.58 0.17 −0.13%
Market cap
$4.3B
P/E
42.2×
Fwd P/E
38.9×
Dividend yield
—
F-score
6/9
Altman Z
2.34
Beneish M
−2.30
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Integer Holdings Corporation (ITGR) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Integer Holdings Corporation (ITGR) trades at a EV/Sales of 3.0×. Over the past ten years it has ranged from 1.7× (October 2016) to 3.8× (September 2018); the current reading is higher than 75% of that period. That is above the Medical Devices industry median of 2.7× and below the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 2.1× (33.01%)
FY2024 3.2× 16.13%
FY2023 2.7× 13.93%
FY2022 2.4× (19.97%)
FY2021 3.0× (4.40%)
FY2020 3.1× 14.58%
FY2019 2.7× (1.27%)
FY2018 2.8× 4.52%
FY2017 2.6× 9.66%
FY2016 2.4× (33.44%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.0× 26.15%
Jun 2026 2.4× 3.79%
Mar 2026 2.3× 9.86%
Dec 2025 2.1× (19.06%)
43 more quarters

Against its own ten years

Low 1.7× High 3.8×
Ten-year median 2.8×
Current reading's percentile 73

EV/Sales against peers

Company EV/Sales
ITGR Integer Holdings Corporation 3.0×
LIVN LivaNova PLC compare 3.2×
NEOG Neogen Corporation compare 3.6×
UFPT UFP Technologies, Inc. compare 3.7×
TMDX TransMedics Group, Inc. compare 3.8×
HAE Haemonetics Corporation compare 4.7×
IRTC iRhythm Holdings, Inc. compare 5.2×
AXGN AxoGen, Inc. compare 8.8×
TXG 10x Genomics compare 11.5×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on ITGR